These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1388649)

  • 21. Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144.
    Kubota A; Kubota S; Farrell HE; Davis-Poynter N; Takei F
    Cell Immunol; 1999 Feb; 191(2):145-51. PubMed ID: 9973537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells.
    Reyburn HT; Mandelboim O; Valés-Gómez M; Davis DM; Pazmany L; Strominger JL
    Nature; 1997 Apr; 386(6624):514-7. PubMed ID: 9087413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
    Agrawal B; Manickasundari M; Fraga E; Singh B
    J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo.
    Farrell HE; Vally H; Lynch DM; Fleming P; Shellam GR; Scalzo AA; Davis-Poynter NJ
    Nature; 1997 Apr; 386(6624):510-4. PubMed ID: 9087412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural killer cells and the MHC class I pathway of peptide presentation.
    Kärre K
    Semin Immunol; 1993 Apr; 5(2):127-45. PubMed ID: 8504217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells.
    Kung SK; Su RC; Graham JJ; Chamberlain JW; Miller RG
    J Immunol; 1998 Jan; 160(2):674-80. PubMed ID: 9551902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rat interleukin-2-activated natural killer (A-NK) cell-mediated lysis is determined by the presence of CD18 on A-NK cells and the absence of major histocompatibility complex class I on target cells.
    Smits KM; Kuppen PJ; Eggermont AM; Tamatani T; Miyasaka M; Fleuren GJ
    Eur J Immunol; 1994 Jan; 24(1):171-5. PubMed ID: 7912675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Licensing of natural killer cells by host major histocompatibility complex class I molecules.
    Kim S; Poursine-Laurent J; Truscott SM; Lybarger L; Song YJ; Yang L; French AR; Sunwoo JB; Lemieux S; Hansen TH; Yokoyama WM
    Nature; 2005 Aug; 436(7051):709-13. PubMed ID: 16079848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In search of the 'missing self': MHC molecules and NK cell recognition.
    Ljunggren HG; Kärre K
    Immunol Today; 1990 Jul; 11(7):237-44. PubMed ID: 2201309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions.
    Ludigs K; Jandus C; Utzschneider DT; Staehli F; Bessoles S; Dang AT; Rota G; Castro W; Zehn D; Vivier E; Held W; Romero P; Guarda G
    Nat Commun; 2016 Feb; 7():10554. PubMed ID: 26861112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer cell education and tolerance.
    Orr MT; Lanier LL
    Cell; 2010 Sep; 142(6):847-56. PubMed ID: 20850008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of T cell responses to a self-antigen following allotransplantation.
    Fedoseyeva EV; Tam RC; Popov IA; Orr PL; Garovoy MR; Benichou G
    Transplantation; 1996 Mar; 61(5):679-83. PubMed ID: 8607166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature.
    Long EO; Colonna M; Lanier LL
    Immunol Today; 1996 Feb; 17(2):100. PubMed ID: 8808061
    [No Abstract]   [Full Text] [Related]  

  • 34. In vivo major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells is regulated by gammadelta T and NK cells during the early steps of tumor growth.
    Riond J; Rodriguez S; Nicolau ML; al Saati T; Gairin JE
    Cancer Immun; 2009 Nov; 9():10. PubMed ID: 19877577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The immune system and cancer.
    Loose D; Van de Wiele C
    Cancer Biother Radiopharm; 2009 Jun; 24(3):369-76. PubMed ID: 19538060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered MHC class I antigens in tumors.
    Algarra I; Collado A; Garrido F
    Int J Clin Lab Res; 1997; 27(2):95-102. PubMed ID: 9266279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of glycans linked to natural killer cell inhibition on the human zona pellucida.
    Patankar MS; Ozgur K; Oehninger S; Dell A; Morris H; Seppala M; Clark GF
    Mol Hum Reprod; 1997 Jun; 3(6):501-5. PubMed ID: 9239739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MHC structure and function.
    Thorsby E
    Transplant Proc; 1999; 31(1-2):713-6. PubMed ID: 10083306
    [No Abstract]   [Full Text] [Related]  

  • 39. Self tolerance of natural MHC class I ligands.
    Rammensee HG; Rötzschke O; Falk K
    Int Rev Immunol; 1993; 10(4):291-300. PubMed ID: 8294842
    [No Abstract]   [Full Text] [Related]  

  • 40. NK cells, MHC class I molecules and the missing self.
    Kärre K
    Scand J Immunol; 2002 Mar; 55(3):221-8. PubMed ID: 11940227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.